BridgeMD
Tests treatment safety and results for Counterpulsation
Official title Effectiveness of ECP Therapy in Stable Angina Pectoris Patients
ClinicalTrials.gov ID: NCT04873687
What this study is testing
- What it's testing
- External Counterpulsation (ECP) is a non-invasive therapy using pressured cuff that is performed on patients with refractory stable angina pectoris to relieve symptoms and increase quality of life. In Indonesia, waiting time for getting coronary artery bypass grafting (CABG) procedure for revascularization treatment in stable angina pectoris patients is way longer than international recommendation which correlates with increase morbidity and mortality during the waiting time.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age \>= 18 years old
- Diagnosed with stable angina pectoris
- Anatomic vessel disease (VD) lesion with 2VD/3VD
- Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the...
- Not planned to urgent CABG
You likely can't join if
- Congestive Heart Failure
- Chronic heart failure with Functional Class NYHA III - IV
- LVEF \<35%
- Unprotected left main stenosis \>50%
- Blood pressure \>180/110mmHg
- Acute coronary syndrome
See the full eligibility criteria
- Age \>= 18 years old
- Diagnosed with stable angina pectoris
- Anatomic vessel disease (VD) lesion with 2VD/3VD
- Indicated for CABG and in waiting list of CABG procedure; or refuse for CABG and choose medical therapy only; or patients who are decided by the responsible doctor for medical treatment alone because of the high risks...
- Not planned to urgent CABG
- Minimum optimal medical therapy within 2 weeks
- Able and willing to sign informed consent and comply with study procedures
- The patient lives in Bandung City and its neighborhood
- Retired patient; or not actively working during working hours; or willing to take the time to participate in research.
- Congestive Heart Failure
- Chronic heart failure with Functional Class NYHA III - IV
- LVEF \<35%
- Unprotected left main stenosis \>50%
- Blood pressure \>180/110mmHg
- Acute coronary syndrome
- Acute Heart Failure
- Severe aorta regurgitation
- Malignant arrhythmia
- Atrial fibrillation
- Premature ventricular complex
- Peripheral occlusive artery disease
- Phlebitis
- Deep vein thrombosis
- Hemorrhagic diathesis
- Severe chronic kidney disease
- Aortic aneurysm
- Abdominal aneurysm
- Osteoarthritis
- Low back pain
- Pregnancy
- Registered as other clinical study participant
The study team makes the final eligibility decision.
Where it's taking place
- Bandung, West Java, Indonesia
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bandung, West Java, Indonesia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.